4.72
price down icon7.45%   -0.38
pre-market  시장 영업 전:  5.28   0.56   +11.86%
loading
전일 마감가:
$5.10
열려 있는:
$5.08
하루 거래량:
3.08M
Relative Volume:
1.17
시가총액:
$1.60B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-9.8333
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
+8.76%
1개월 성능:
-34.08%
6개월 성능:
-42.23%
1년 성능:
-45.68%
1일 변동 폭
Value
$4.59
$5.11
1주일 범위
Value
$4.28
$5.265
52주 변동 폭
Value
$3.96
$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name
명칭
Bausch Health Companies Inc
Name
전화
514-744-6792
Name
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Name
직원
20,700
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
BHC's Discussions on Twitter

BHC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
BHC
Bausch Health Companies Inc
4.72 1.60B 9.47B -178.00M 1.01B -0.48
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.85 67.28B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.19 45.61B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.93 45.01B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
13.31 15.25B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
284.25 12.77B 2.76B 1.11B 898.10M 22.77

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-02 다운그레이드 Piper Sandler Neutral → Underweight
2024-07-10 개시 Raymond James Mkt Perform
2023-09-20 업그레이드 Jefferies Hold → Buy
2023-06-16 다운그레이드 TD Cowen Outperform → Market Perform
2022-07-29 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-07-29 다운그레이드 Truist Buy → Hold
2022-07-28 다운그레이드 JP Morgan Overweight → Neutral
2022-06-13 재개 JP Morgan Overweight
2021-03-24 다운그레이드 BofA Securities Neutral → Underperform
2021-02-17 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2021-01-22 다운그레이드 Piper Sandler Overweight → Neutral
2020-09-17 업그레이드 BofA Securities Underperform → Neutral
2020-08-24 재확인 H.C. Wainwright Buy
2020-06-17 재확인 H.C. Wainwright Buy
2020-04-24 개시 Citigroup Buy
2020-04-02 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-01-29 다운그레이드 Wolfe Research Outperform → Peer Perform
2020-01-22 업그레이드 Wells Fargo Underweight → Equal Weight
2019-12-12 업그레이드 JP Morgan Neutral → Overweight
2019-12-02 개시 Goldman Neutral
2019-10-25 개시 Cowen Outperform
2019-09-12 개시 Guggenheim Buy
2019-08-15 업그레이드 TD Securities Hold → Buy
2019-07-19 개시 Wolfe Research Outperform
2019-06-11 재개 Barclays Overweight
2019-05-13 업그레이드 JP Morgan Underweight → Neutral
2019-03-20 개시 SunTrust Buy
2019-01-02 업그레이드 Piper Jaffray Neutral → Overweight
2018-11-05 업그레이드 Morgan Stanley Equal-Weight → Overweight
2018-09-13 업그레이드 Piper Jaffray Underweight → Neutral
모두보기

Bausch Health Companies Inc 주식(BHC)의 최신 뉴스

pulisher
08:18 AM

Bausch Health stock jumps after Carl Icahn stake (BHC:NYSE) - Seeking Alpha

08:18 AM
pulisher
08:16 AM

Bausch Health updates proxy statement on Icahn’s interest - Investing.com

08:16 AM
pulisher
08:13 AM

Bausch Health Addresses Icahn’s Equity Swaps and Adopts Shareholder Rights Plan - TipRanks

08:13 AM
pulisher
07:46 AM

Bausch Health shares surge on Icahn’s significant economic interest - Investing.com

07:46 AM
pulisher
07:32 AM

Bausch Health Brief: Filing Supplement In Response to Co Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares - marketscreener.com

07:32 AM
pulisher
07:32 AM

Bausch Health Announces Filing of Supplement to Proxy Statement - standard-journal.com

07:32 AM
pulisher
07:30 AM

Press Release Distribution & PR Platform - ACCESS Newswire

07:30 AM
pulisher
07:25 AM

Carl Icahn's Secret 34% Bausch Health Stake Triggers Defensive Poison Pill Response - Stock Titan

07:25 AM
pulisher
07:20 AM

April 2025's Top Growth Stocks With Strong Insider Ownership - simplywall.st

07:20 AM
pulisher
Apr 21, 2025

BofA Cuts Price Target on Bausch Health to $5 From $7 - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

TSX falls as Trump's Fed criticism shakes markets - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Bausch (BHC) Moves 13.3% Higher: Will This Strength Last? - Nasdaq

Apr 21, 2025
pulisher
Apr 20, 2025

Analysts Expect Bausch Health Companies Inc. (NYSE:BHC) To Breakeven Soon - simplywall.st

Apr 20, 2025
pulisher
Apr 19, 2025

Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in? - Yahoo Finance

Apr 19, 2025
pulisher
Apr 19, 2025

11 Ridiculously Cheap Stocks to Invest in - Insider Monkey

Apr 19, 2025
pulisher
Apr 17, 2025

Bausch Health Provides Update on Solta Medical - marketscreener.com

Apr 17, 2025
pulisher
Apr 17, 2025

U.S. District Court Rules in Favor of Bausch Health and FDA in XIFAXAN Case - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Bausch Health shares jump on favorable court ruling By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Bausch Health shares jump on favorable court ruling - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

Bausch says court grants summary judgment in favor of FDA, Salix, and Teva - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Major Legal Win: How Bausch Health's Court Victory Protects Billion-Dollar XIFAXAN Franchise Until 2028 - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

Fitch raises Bausch Health rating to CCC+ amid refinancing By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 17, 2025

Fitch raises Bausch Health rating to CCC+ amid refinancing - Investing.com

Apr 17, 2025
pulisher
Apr 17, 2025

Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk - Bloomberg.com

Apr 17, 2025
pulisher
Apr 16, 2025

Topical Drug Delivery Market Set to Witness Significant Growth - openPR.com

Apr 16, 2025
pulisher
Apr 16, 2025

Verteporfin Market Generated Opportunities, Future Scope - openPR.com

Apr 16, 2025
pulisher
Apr 15, 2025

Bausch Health Companies IncAdopts Shareholder Rights PlanSEC Filing - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Scar Treatment Market Set to Witness Significant Growth - openPR.com

Apr 15, 2025
pulisher
Apr 14, 2025

Bausch Health Adopts Shareholder Rights Plan to Ensure Fair Treatment - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Bausch Health Announces Adoption of Shareholder Rights Plan - The Joplin Globe

Apr 14, 2025
pulisher
Apr 14, 2025

Bausch Health's New Poison Pill Defense: Key Details of Shareholder Protection Strategy - Stock Titan

Apr 14, 2025
pulisher
Apr 14, 2025

The most oversold and overbought stocks on the TSX - The Globe and Mail

Apr 14, 2025
pulisher
Apr 14, 2025

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Intraocular Lens Market Overall Study Report 2025-2032 | Bausch - openPR.com

Apr 14, 2025
pulisher
Apr 10, 2025

Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

New $10K Scholarship Program Empowers Students Affected by Skin Conditions - Stock Titan

Apr 10, 2025
pulisher
Apr 09, 2025

Bausch Health secures intent for acne treatment coverage By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Atopic Dermatitis Pipeline 2025: Therapies Under - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

Bausch Health signs LOI with pan-Canadian Pharmaceutical Alliance for CABTREO - TipRanks

Apr 09, 2025
pulisher
Apr 09, 2025

Bausch Health Canada signs Cabtreo public drug plan coverage letter of intent - TipRanks

Apr 09, 2025
pulisher
Apr 09, 2025

Bausch Health secures intent for acne treatment coverage - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Bausch Health Companies Unit Entered Into A New Senior Secured Credit Agreement - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

First-Ever Triple-Action Acne Treatment Now Covered by Canadian Public Drug Plans - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 08, 2025

Bausch Health Misses Revenue Estimates, RBC Analysts React - Finimize

Apr 08, 2025
pulisher
Apr 07, 2025

Bausch Health Faces Revenue Miss And Price Target Cut - Finimize

Apr 07, 2025
pulisher
Apr 07, 2025

Alex Meruelo Reports 9.99% Stake In Bausch Health Companies Inc As Of March 31SEC Filing - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Sector Update: Health Care Stocks Slipping in Late Afternoon Trading - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

Bausch Health Faces Challenges Amid Price Target Downgrade - Evrim Ağacı

Apr 07, 2025
pulisher
Apr 07, 2025

Bausch Health stock target cut to $8.50 by RBC Capital - Investing.com South Africa

Apr 07, 2025

Bausch Health Companies Inc (BHC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$8.48
price up icon 0.47%
$27.00
price up icon 0.00%
$100.62
price down icon 0.69%
$7.57
price up icon 0.13%
$100.68
price down icon 0.69%
$284.25
price down icon 0.17%
자본화:     |  볼륨(24시간):